Cargando…
Novel Therapies of Hepatitis B and D
Hepatitis B virus (HBV) infection is a global public health issue and is a major cause of cirrhosis and hepatocellular carcinoma (HCC). Hepatitis D virus (HDV) requires the hepatitis B surface antigen (HBsAg) to replicate. The eradication of HBV, therefore, can also cure HDV. The current therapies f...
Autores principales: | Khan, Iman Waheed, Dad Ullah, Mati Ullah, Choudhry, Mina, Ali, Mukarram Jamat, Ali, Muhammad Ashar, Lam, Sam L. K., Shah, Pir Ahmad, Kaur, Satinder Pal, Lau, Daryl T. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707465/ https://www.ncbi.nlm.nih.gov/pubmed/34946209 http://dx.doi.org/10.3390/microorganisms9122607 |
Ejemplares similares
-
Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
por: Hanif, Hira, et al.
Publicado: (2022) -
Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022) -
An update on the management of chronic hepatitis D
por: Shah, Pir Ahmad, et al.
Publicado: (2019) -
A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Hanif, Hira, et al.
Publicado: (2020) -
Improved hepatitis A and hepatitis B vaccination strategy is necessary for patients with chronic hepatitis C
por: Maqsood, Muhammad H, et al.
Publicado: (2020)